# | Drug | Count |
---|---|---|
0 | NIRAPARIB | 1706 |
1 | RUCAPARIB | 556 |
2 | OLAPARIB | 222 |
3 | BEVACIZUMAB | 184 |
4 | ERGOCALCIFEROL | 167 |
5 | GABAPENTIN | 140 |
6 | LORAZEPAM | 129 |
7 | LISINOPRIL | 120 |
8 | METOPROLOL TARTRATE | 114 |
9 | METOPROLOL | 108 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | PIPERINE | 1 | 0.2000 |
1 | NIRAPARIB | 1706 | 0.0981 |
2 | RUCAPARIB | 556 | 0.0674 |
3 | FERRIC SUBSULFATE | 1 | 0.0455 |
4 | METHENAMINE, BENZOIC ACID, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0357 |
5 | MIRVETUXIMAB SORAVTANSINE | 3 | 0.0268 |
6 | DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0256 |
7 | OLAPARIB | 222 | 0.0189 |
8 | SHARK CARTILAGE | 1 | 0.0128 |
9 | PASSION FLOWER | 1 | 0.0123 |
# | Drug class | Count |
---|---|---|
0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1918 |
1 | Benzodiazepine [EPC] | 212 |
2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 193 |
3 | Provitamin D2 Compound [EPC] | 167 |
4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 165 |
5 | Vitamin C [EPC] | 130 |
6 | Factor Xa Inhibitor [EPC] | 105 |
7 | Corticosteroid [EPC] | 100 |
8 | Osmotic Laxative [EPC] | 100 |
9 | Platinum-based Drug [EPC] | 100 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1918 | 0.0660 |
1 | Nitrogen Binding Agent [EPC] | 1 | 0.0100 |
2 | Phenothiazine [EPC] | 48 | 0.0021 |
3 | Cannabinoid [EPC] | 12 | 0.0015 |
4 | Folate Analog [EPC] | 1 | 0.0015 |
5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 193 | 0.0013 |
6 | Methylating Agent [EPC] | 1 | 0.0012 |
7 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0011 |
8 | Aromatase Inhibitor [EPC] | 91 | 0.0010 |
9 | Serotonin-3 Receptor Antagonist [EPC] | 88 | 0.0009 |